Startseite - Psoriasis-News

Dermoscopy vs. histopathology in palmoplantar psoriasis and hyperkeratotic eczema: a cross-sectional study
Dermoscopy vs. histopathology in palmoplantar psoriasis and hyperkeratotic eczema: a cross-sectional study

ein Artikel von Redaktion in PubMed
- vor 17 Stunden17 h
- 0 Antworten
CGRP levels in autoimmune diseases: a systematic review and meta-analysis of its potential role as a biomarker
CGRP levels in autoimmune diseases: a systematic review and meta-analysis of its potential role as a biomarker

ein Artikel von Redaktion in PubMed
- vor 17 Stunden17 h
- 0 Antworten
Immunomodulatory Probiotics in Psoriasis: Effects on the Gut-Skin-Immune Crosstalk and Systemic Inflammation: Immunomodulatory Probiotics and Psoriasis Disease
Immunomodulatory Probiotics in Psoriasis: Effects on the Gut-Skin-Immune Crosstalk and Systemic Inflammation: Immunomodulatory Probiotics and Psoriasis Disease

ein Artikel von Redaktion in PubMed
- vor 17 Stunden17 h
- 0 Antworten
Integrated Transcriptomic and Single-Cell RNA Sequencing Analyses Identify Shared Inflammation-Related Candidate Genes in Psoriasis and Acute Myocardial Infarction
Integrated Transcriptomic and Single-Cell RNA Sequencing Analyses Identify Shared Inflammation-Related Candidate Genes in Psoriasis and Acute Myocardial Infarction

ein Artikel von Redaktion in PubMed
- vor 17 Stunden17 h
- 0 Antworten
Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis
Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis

ein Artikel von Redaktion in PubMed
- vor 17 Stunden17 h
- 0 Antworten
Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis
Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade
Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
The Value of Systemic Inflammatory Parameters (Neutrophil-Lymphocyte Ratio and C-Reactive Protein) Combined with Psoriasis Area Severity Index in Predicting the Development of Arthritic Symptoms in Patients with Psoriasis
The Value of Systemic Inflammatory Parameters (Neutrophil-Lymphocyte Ratio and C-Reactive Protein) Combined with Psoriasis Area Severity Index in Predicting the Development of Arthritic Symptoms in Patients with Psoriasis

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience
Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
Psoriasis undercover! : Relevance of advanced diagnostics in occupational dermatology
Psoriasis undercover! : Relevance of advanced diagnostics in occupational dermatology

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
Cathepsin S drives keratinocyte IL-8/ICAM-1-mediated neutrophilic inflammation in generalized pustular psoriasis and induces a pustular psoriasis-like phenotype in mice
Cathepsin S drives keratinocyte IL-8/ICAM-1-mediated neutrophilic inflammation in generalized pustular psoriasis and induces a pustular psoriasis-like phenotype in mice

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
Development and External Evaluation of a Clinical Score for High Pretreatment Interferon-gamma Release Assay Responses in Psoriasis: A Multicenter Study in China
Development and External Evaluation of a Clinical Score for High Pretreatment Interferon-gamma Release Assay Responses in Psoriasis: A Multicenter Study in China

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
Rare LAMA4 variants identified in Egyptian familial psoriasis vulgaris
Rare LAMA4 variants identified in Egyptian familial psoriasis vulgaris

ein Artikel von Redaktion in PubMed
- Montag 11:001 Tag
- 0 Antworten
In vitro studies on the therapeutic potential of hybrid hydrogels loaded polymeric carriers - Salicylic acid and fluocinolone acetonide systems based on 3D psoriasis model
In vitro studies on the therapeutic potential of hybrid hydrogels loaded polymeric carriers - Salicylic acid and fluocinolone acetonide systems based on 3D psoriasis model

ein Artikel von Redaktion in PubMed
- Sonntag 11:002 Tage
- 0 Antworten
Effectiveness and Safety of Vunakizumab Over 12 Weeks in Chinese Patients With Plaque Psoriasis: A Prospective, Real-World Cohort Study
Effectiveness and Safety of Vunakizumab Over 12 Weeks in Chinese Patients With Plaque Psoriasis: A Prospective, Real-World Cohort Study

ein Artikel von Redaktion in PubMed
- Sonntag 11:002 Tage
- 0 Antworten
A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adults with psoriasis vulgaris or psoriatic arthritis
A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adults with psoriasis vulgaris or psoriatic arthritis

ein Datensatz von Redaktion in Neu registrierte Studien in Deutschland
- Samstag 00:004 Tage
- 0 Antworten
EffisayilTM ON: An open-label, long term extension study to assess the safety and efficacy of spesolimab treatment in patients with Generalized Pustular Psoriasis (GPP)
EffisayilTM ON: An open-label, long term extension study to assess the safety and efficacy of spesolimab treatment in patients with Generalized Pustular Psoriasis (GPP)

ein Datensatz von Redaktion in Neu registrierte Studien in Deutschland
- Samstag 00:004 Tage
- 0 Antworten
A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Deucravacitinib in Adolescent Subjects (12 years to less than 18 years) with Moderate to Severe Plaque Psoriasis
A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Deucravacitinib in Adolescent Subjects (12 years to less than 18 years) with Moderate to Severe Plaque Psoriasis

ein Datensatz von Redaktion in Neu registrierte Studien in Deutschland
- Samstag 00:004 Tage
- 0 Antworten
A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Deucravacitinib in Adolescent Subjects (12 years to less than 18 years) with Moderate to Severe Plaque Psoriasis
A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Deucravacitinib in Adolescent Subjects (12 years to less than 18 years) with Moderate to Severe Plaque Psoriasis

ein Datensatz von Redaktion in Neu registrierte Studien in Deutschland
- Samstag 00:004 Tage
- 0 Antworten
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects with Moderate-to-Severe Plaque Psoriasis
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects with Moderate-to-Severe Plaque Psoriasis

ein Datensatz von Redaktion in Neu registrierte Studien in Deutschland
- 22. Oktober22. Okt
- 0 Antworten

Letzte Aktivitäten

Dermoscopy vs. histopathology in palmoplantar psoriasis and hyperkeratotic eczema: a cross-sectional study

CGRP levels in autoimmune diseases: a systematic review and meta-analysis of its potential role as a biomarker

Immunomodulatory Probiotics in Psoriasis: Effects on the Gut-Skin-Immune Crosstalk and Systemic Inflammation: Immunomodulatory Probiotics and Psoriasis Disease

Integrated Transcriptomic and Single-Cell RNA Sequencing Analyses Identify Shared Inflammation-Related Candidate Genes in Psoriasis and Acute Myocardial Infarction

Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis

Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis

Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade

The Value of Systemic Inflammatory Parameters (Neutrophil-Lymphocyte Ratio and C-Reactive Protein) Combined with Psoriasis Area Severity Index in Predicting the Development of Arthritic Symptoms in Patients with Psoriasis

Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience

Psoriasis undercover! : Relevance of advanced diagnostics in occupational dermatology

Cathepsin S drives keratinocyte IL-8/ICAM-1-mediated neutrophilic inflammation in generalized pustular psoriasis and induces a pustular psoriasis-like phenotype in mice

Development and External Evaluation of a Clinical Score for High Pretreatment Interferon-gamma Release Assay Responses in Psoriasis: A Multicenter Study in China

Rare LAMA4 variants identified in Egyptian familial psoriasis vulgaris

In vitro studies on the therapeutic potential of hybrid hydrogels loaded polymeric carriers - Salicylic acid and fluocinolone acetonide systems based on 3D psoriasis model

Effectiveness and Safety of Vunakizumab Over 12 Weeks in Chinese Patients With Plaque Psoriasis: A Prospective, Real-World Cohort Study

A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adults with psoriasis vulgaris or psoriatic arthritis

EffisayilTM ON: An open-label, long term extension study to assess the safety and efficacy of spesolimab treatment in patients with Generalized Pustular Psoriasis (GPP)

A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Deucravacitinib in Adolescent Subjects (12 years to less than 18 years) with Moderate to Severe Plaque Psoriasis

A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Deucravacitinib in Adolescent Subjects (12 years to less than 18 years) with Moderate to Severe Plaque Psoriasis

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects with Moderate-to-Severe Plaque Psoriasis

Konto

Navigation

Suche

Browser-Push-Nachrichten konfigurieren

Chrome (Android)

Chrome (Desktop)

Safari (iOS 16.4+)

Safari (macOS)

Edge (Android)

Edge (Desktop)

Firefox (Android)

Firefox (Desktop)